Abstract
Deep learning (DL) methods have been increasingly applied to neuroimaging data to identify patients with psychiatric and neurological disorders. This review provides an overview of the different DL applications within psychiatry and compares DL model accuracy to conventional machine learning (ML). Fifty-three articles were included for qualitative analysis, primarily investigating autism spectrum disorder (ASD; n=22), schizophrenia (SZ; n=22) and attention-deficit/hyperactivity disorder (ADHD; n=9). Thirty-two of the thirty-five studies that directly compared DL to ML reported a higher accuracy for DL. Only sixteen studies could be included in a meta-regression to quantitatively compare DL and ML performance. This showed a higher odds ratio for DL models, though the comparison attained significance only for ASD. These results suggest that deep learning of neuroimaging data is a promising tool for the classification of individual psychiatric patients. The current evaluation is limited by minimal reporting of performance measures to enable quantitative comparisons, and the restriction to ADHD, SZ and ASD as current research focusses on large publicly available datasets.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
n/a